Evidence map›Paper›PMID 32628714›Full record

ArticlePloS one2020

Tackling cryptococcal meningitis in Nigeria, one-step at a time; the impact of training.

Rita O Oladele, Alexander Jordan, Patrick Akande, Sulaimon A Akanmu, Iorhen E Akase, Sani Aliyu, David W Denning, Tom Chiller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Rita O OladeleCollege of Medicine, University of Lagos, Lagos, Nigeria.ORCID 0000-0003-1488-3345
Alexander JordanMycotic Diseases Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America.
Patrick AkandeAPIN Public Health Initiatives, Abuja, Nigeria.ORCID 0000-0002-4138-0594
Sulaimon A AkanmuCollege of Medicine, University of Lagos, Lagos, Nigeria.
Iorhen E AkaseCollege of Medicine, University of Lagos, Lagos, Nigeria.
Sani AliyuNational Agency for the Control of AIDS (NACA), Abuja, Nigeria.
David W DenningGlobal Action Fund for Fungal Infections (GAFFI), Geneva, Switzerland.
Tom ChillerMycotic Diseases Branch, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America.
University of Lagos · NGCenters for Disease Control and Prevention · USAIDS Prevention Initiative in Nigeria · NGGlobal Fund to Fight AIDS, Tuberculosis and Malaria · CHNational Agency for the Control of AIDS · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNigeria is estimated to have 25,000 cases of cryptococcal antigenemia (CrAg) annually. CrAg screening with pre-emptive fluconazole treatment is recommended but not yet implemented in Nigeria. Trainings were conducted to improve health-care provider (HCP) awareness and clinical skills in the management and prevention of cryptococcal meningitis (CM).

methodsHCPs providing care for people living with HIV were targeted for training at 13 sites from April to November 2018 Course content was adapted from CDC Cryptococcal Screening Program Training Manual and LIFE-website. "Hands-on" training on CrAg testing and lumbar puncture was included. A 14-point pre and post-test assessment instrument was designed to capture the impact of the training and focus group discussions (FGDs) were conducted.

resultsA total of 761 HCPs were trained. 519 HCPs completed the pre-test evaluation while 470 (90.6%) took part in the post-test evaluation. Post-training, HCPs were significantly more likely to respond correctly to all 14 assessment items, with the mean percentage score rising to 91.0% from a pre-training value of 60.0%. FGDs revealed that many of the HCPs were not aware of the CrAg screening and pre-emptive treatment recommendations in Nigerian guidelines, and reported not having seen or managed a case of CM. Also, they highlighted challenges with routine CrAg screening due to a lack of access to CD4 testing, CrAg test kits, antifungal drugs, as well as the need for similar trainings across all tiers of care in Nigeria.

conclusionTraining significantly improved HCPs' understanding of Nigerian policy on CrAg screening, CM diagnosis and best management practices. This training could be included in routine capacity building efforts for HCPs involved in HIV care in Nigeria.

Indexed as

Focus GroupsHealth PersonnelHumansMeningitis, CryptococcalNigeriaPatient Care

Identifiers

PMID32628714
PMCPMC7337344
OpenAlexW3037274771

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.